Clostridium difficile is an opportunistic diarrhoeal pathogen, and C. difficile infection (CDI) represents a major health care concern, causing an estimated 15,000 deaths per year in the United States alone 1 . Several enteric pathogens, including C. difficile, leverage inflammation and the accompanying microbial dysbiosis to thrive in the distal gut 2 . Although diet is among the most powerful available tools for affecting the health of humans and their relationship with their microbiota, investigation into the effects of diet on CDI has been limited. Here, we show in mice that the consumption of microbiota-accessible carbohydrates (MACs) found in dietary plant polysaccharides has a significant effect on CDI. Specifically, using a model of antibiotic-induced CDI that typically resolves within 12 days of infection, we demonstrate that MAC-deficient diets perpetuate CDI. We show that C. difficile burdens are suppressed through the addition of either a diet containing a complex mixture of MACs or a simplified diet containing inulin as the sole MAC source. We show that switches between these dietary conditions are coincident with changes to microbiota membership, its metabolic output and C. difficile-mediated inflammation. Together, our data demonstrate the outgrowth of MAC-utilizing taxa and the associated end products of MAC metabolism, namely, the short-chain fatty acids acetate, propionate and butyrate, are associated with decreased C. difficile fitness despite increased C. difficile toxin expression in the gut. Our findings, when placed into the context of the known fibre deficiencies of a human Western diet, provide rationale for pursuing MAC-centric dietary strategies as an alternate line of investigation for mitigating CDI.
whereas mice fed the MAC + diet clear the pathogen below detection within 10 days of infection. After 36 days of persistent infection in mice fed the MD diets, a dietary shift to the MAC + diet results in clearance below detection within 9 days (Fig. 1a ). This MAC + diet-mediated CDI suppression is also observed in conventional C57BL/6 and Swiss-Webster mice and in ex-germ-free Swiss-Webster mice colonized with a conventional Swiss-Webster mouse microbiota ( Supplementary Fig. 1 ), demonstrating that MACdependent CDI suppression is not confined to a specific microbiota or host genotype.
To enumerate gut-resident microorganisms that might suppress C. difficile, we sequenced 16S rRNA amplicons from the faeces of humanized mice (Fig. 1a) . The presence of dietary MACs and treatment with antibiotics affected both alpha and beta diversity of operational taxonomic units (OTUs) in the gut microbiota ( Fig. 1b-d and Supplementary Figs. 2 and 3) . Two principle coordinates (PCo) explain 48% of the variance in weighted UniFrac distances between samples. We traced temporal changes in the composition of the microbiota through this space. To highlight the composition of the microbiota in the context of CDI, a log-fold contour plot was drawn to illustrate burdens of C. difficile that correspond to these samples (see Supplementary Fig. 4 for further explanation of these 'contoured PCo analysis' (cPCoA) plots).
Clindamycin remodels the mouse microbiome to a C. difficilepermissive state ( Fig. 1b-d , dotted lines; Supplementary Fig. 3 ). After inoculation with C. difficile, the microbiota of MAC + -fed mice changes significantly, and as C. difficile burdens decrease, the community returns to resemble the pre-infection state ( Fig. 1b and Supplementary Fig. 3a ), illustrating compositional resilience of the microbiota under the MAC + dietary condition during CDI. During persistent infection in mice fed the MD diets, the microbiota composition is similar to the pre-infection MD-associated microbiota. However, after the MAC + dietary intervention, the microbiota of these mice transitions to resemble the microbiota of mice prophylactically fed the MAC + diet as C. difficile burdens decrease (Fig. 1c,d and Supplementary Fig. 3b,c) . These data indicate that diet and antibiotic treatment are two major drivers of microbial communities that support or exclude C. difficile in our model. Furthermore, the similarities in the microbiota of uninfected and persistently infected mice fed the MD diets may be due to the metabolic and compositional constraints imposed by this dietary condition, which we hypothesize is supportive to C. difficile during infection.
In a previous report, in mice that cleared CDI below the limit of detection, C. difficile shedding could be re-initiated upon clindamycin treatment up to approximately 12 weeks after establishment of low-level carriage 11 , consistent with mice harbouring C. difficile in Letters Nature Microbiology the absence of disease and not having developed protective immunity. Similarly, in our model, the persistently infected state cannot be re-established in mice fed a MAC-rich diet that cleared CDI below detection upon switching them to the MD1 diet (that is, in the absence of antibiotics). However, persistent infection can be reestablished if mice are first switched to the MD1 diet and treated with clindamycin ( Supplementary Fig. 5 ).
Having shown that the MAC + diet, containing a complex and ill-defined mixture of MACs (see Methods), is successful in suppressing CDI, we sought to decouple the effects of MACs from other dietary components (for example, phytonutrient 12 or protein 13 content). Using a simplified MD1-based diet containing inulin as the sole MAC source, the findings from our initial dietary intervention experiment in C. difficile-infected animals are recapitulated ( Fig. 2a and Supplementary Fig. 6 ). Furthermore, prophylactic inulin feeding (either 10% in the diet as above or 1% in the drinking water of mice fed the MD1 diet), results in dosedependent effects on both the maximum C. difficile burden and on C. difficile clearance kinetics ( Supplementary Fig. 7 ). Taken together, like the complex MAC + diet, inulin feeding reduces C. difficile burdens across experimental paradigms ( Fig. 2a and Supplementary Figs. 6-8).
Notably, 2 of the 16 mice that were given inulin-based dietary interventions failed to clear C. difficile below detection ( Supplementary Figs. 6a and 8 ). However, a critical C. difficile virulence factor, the glycosylating toxin TcdB 14 , is not detectable in these mice (or in the MAC + -fed mice that cleared C. difficile below detection) at the end point of this experiment ( Supplementary Fig. 6b ). In one study that examined toxin concentrations quantitatively in adults, CDI severity was correlated with faecal toxin level 15 , ranging from asymptomatic carriage to fulminant colitis (up to 15% of healthy adults are asymptomatically colonized with C. difficile 16 ). However, C. difficile toxin levels are typically not quantified in current clinical diagnostic procedures, which involve either the qualitative assessment of toxin by immunoassay, in vitro cytotoxicity assay or PCR-based detection of toxin genes 17 . This raises the possibility that MACs may have a role in limiting C. difficile burdens below a pathogenic threshold in carriers.
Although the complex MAC + and the inulin-containing diets both negatively affect the in vivo fitness of C. difficile, the overall microbiome composition differs between mice that were fed these two diets, as illustrated by a two-dimensional cPCoA subspace that explains 62% of the variation in the data and the proportional abundance of taxa ( Fig. 2b and Supplementary Figs. 9 and 10). Clindamycin affects the composition of the microbiota in all groups of mice from day -1 (annotated with the ellipses, day 0 (dashed lines)), resulting in a dysbiotic state permissive to CDI. In each panel, a line is drawn through the centroid of the points for a given experimental day. In mice fed the MAC + diet, the microbiota returns to resemble the pre-infection state as C. difficile burdens decrease (b). In mice fed the MD1 (c) and MD2 (d) diets, CDI remains unresolved until dietary intervention with the MAC + diet at day 36, which shifts the microbiota to resemble that of other MAC + -fed mice as C. difficile burdens decrease (brown lines). Points are coloured by the highlighted treatment group or, alternatively, are retained as grey points for reference. See Supplementary Fig. 4 for further explanation on the generation and interpretation of the cPCoA plots shown in panels b-d.
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Because increased gut microbiota diversity is associated with resistance to several pathogens and is a hallmark of faecal microbiota transplantation-mediated suppression of CDI 6,18-20 , one hypothesis is that MACs positively affect CDI outcome by favouring a diverse microbiota. Although CDI suppression induced by the MAC + diet is correlated with an increase in alpha diversity of the gut microbiota, alpha diversity does not increase when C. difficile burdens decrease via inulin feeding ( Fig. 2c and Supplementary Fig. 11a ). Furthermore, community evenness is lowest in the inulin-fed mice ( Supplementary Fig. 11b ), consistent with a limited number of taxa that profit from a single MAC type 21 . Together, these data demonstrate that MACs significantly reduce C. difficile burdens, but that this reduction is independent of microbiota diversity. Despite these wholesale differences in community composition, we pursued two of several possibilities: (1) a common subset of OTUs suppresses CDI across dietary interventions or (2) diet-specific but functionally similar OTUs within dietary conditions suppress CDI. To identify OTUs that are predictive of C. difficile presence or that discriminate between dietary conditions (Supplementary Table 1 , fields 'Plus_minus_Cd' and 'Current_diet, ' respectively), we performed supervised (random forests) and unsupervised (non-parametric tests for differential abundance) analyses on OTUs identified in this study. All of the features identified by the supervised analysis as the most discriminating between CDI state and diet for each comparison group (n = 15 for each classifier) were also identified by the unsupervised analysis (Bonferroni-corrected P < 0.05; Supplementary  Table 2 ). Spearman correlation analyses were then performed between these features and C. difficile burdens, refining a list of highconfidence taxa that are predictive of C. difficile burdens (Spearman ρ with Bonferroni-corrected P < 0.05; Supplementary Table 3 ).
Notably, several taxa are significantly (anti)correlated with C. difficile burdens regardless of diet, suggesting that common microbial signatures underlie permissive and non-permissive states ( Supplementary Table 3 ). Among these, Parabacteroides, Lachnospiraceae and Erysipelotrichaceae are correlated with C. difficile abundance regardless of diet. The correlation between Parabacteroides and C. difficile burden is consistent with previous observations that Parabacteroides counts are elevated in C. difficile 'supershedder' mice 22 . In humans, Erysipelotrichaceae and some Lachnospiraceae are enriched in individuals with CDI compared to non-diarrhoeal controls 23 . Despite these commonalities, the majority of features identified in Supplementary Table 3 are (anti) correlated with C. difficile in a subset of diets, supporting previous work that distinct context-dependent communities, rather than core C. difficile-(un)supportive communities, are important for determining CDI status 24 . Because others have demonstrated that metabolites, rather than microorganisms, are able to differentiate CDI status in humans 25 , we hypothesized that diet creates metabolic landscapes that are either supportive or unsupportive of C. difficile.
Thus, we pursued whether MAC-mediated suppression of CDI could be differentiated from the permissive condition on a molecular basis relevant to MAC metabolism. We measured the major metabolic end products of MAC metabolism (the short-chain fatty acids (SCFAs) acetate, propionate and butyrate) in caecal contents of mice (see Supplementary Fig 6) . Acetate and butyrate levels are elevated in the caeca of mice fed the MAC + and inulin diets relative to those fed the MD1 diet, and propionate levels are elevated in the caeca of MAC + -fed mice relative to those fed the MD1 or inulin diets ( Fig. 3a ). Furthermore, acetate, propionate and butyrate have concentration-dependent negative effects on C. difficile growth Supplementary Fig. 4 for further explanation on the generation and interpretation of cPCoA plots. c, Alpha diversity of communities was determined longitudinally for the microbiota of these mice by the Shannon diversity index. Differences in C. difficile burdens and alpha diversity between dietary conditions were determined by collapsing all time points after the diet shift time point. In the box and whiskers plot shown, the box extends from the 25th to 75th percentiles, with the central line in each box representing the median value of the data set. The whiskers extend from the smallest to the largest values in the data sets. See Supplementary Fig. 11 for temporal differences in the Shannon diversity index. Significance was determined by the Kruskal-Wallis test with the Dunn's multiple comparison test (****P < 0.0001; see also Supplementary Table 5 ).
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as measured by differences in doubling time ( Fig. 3b ) and concentration-dependent positive effects on the expression of TcdB 14 (Fig. 3c ). Our findings using the C. difficile strain 630 are consistent with previous findings in other C. difficile strains: (1) SCFAs inhibit the growth of five non-630 strains in a concentration-dependent manner 10, 26 and (2) butyrate affects toxin expression in the C. difficile strain VPI 10463 (ref. 27 ). Given these findings, we hypothesized that dietary MACs negatively affect the fitness of C. difficile in two inter-related ways. First, MACs drive privileged outgrowth of MAC-utilizing members of the microbiota (for example, Bacteroides spp.; see Supplementary  Table 2b ). Second, the SCFAs that result from MAC metabolism negatively affect the fitness of C. difficile, which could be due to the buildup of end products of key metabolic pathways, such as reductive acetogenesis and butyrogenesis 5, 28 . The expression of TcdB (and the co-regulated toxin TcdA) in C. difficile is controlled by multiple inputs, such as nutrient availability, quorum sensing and other environmental stresses 29 . Thus, it is possible that SCFAs serve as a signal to C. difficile of microbiome fermentation, and this signal of a competitive and inhospitable gut environment leads to an increase in toxin production.
As limitation of dietary MACs is known to increase inflammation in the gastrointestinal tract 7 , we examined colonic histopathology and toxin levels to better understand the inflammation during MAC-dependent suppression of CDI. Humanized Swiss-Webster mice fed the MD1 diet were infected as in Fig. 1a and were switched to either the MAC + or inulin diet at 7 days post-infection. At prediet and post-diet shift time points, histopathology of proximal colon tissue was evaluated. Pathology was significantly increased in all infected mice relative to uninfected control mice fed the MAC + or inulin diets ( Fig. 4a , Supplementary Fig. 12 and Supplementary  Table 4 ). Notably, the levels of inflammation were comparably elevated in both infected and uninfected mice fed the MD1 diet, which is consistent with the contribution of the MD diets to inflammation and C. difficile persistence.
We also measured the burdens of C. difficile and the levels of TcdB in faeces during the shift from the MD1 diet to either the MAC + or inulin diets. TcdB is detected during persistent infection but its expression is further elevated at 2 and 4 days after the shift to the MAC + or inulin diet (Fig. 4b) . Although colony-forming unit (c.f.u.)-normalized TcdB abundance is increased after the diet shift, the overall abundance of TcdB decreases from day 2 to day 4 postdiet shift ( Supplementary Fig. 13 ). This shows that toxin expression is elevated on a per-cell basis in response to MACs but that the overall TcdB abundance scales with decreasing burdens of C. difficile. Together, these data support a model in which MD diets facilitate a level of inflammation supportive of C. difficile survival in the gut, enabling C. difficile persistence despite the lower levels of toxin expression. C. difficile responds to the non-permissive MAC-driven environmental change by elevating toxin expression. However, C. difficile is unable to maintain or regain its niche in the gastrointestinal tract upon the sustained consumption of MACs by the host.
In the context of CDI, the relative contribution of inflammation to the exclusion of inflammation-sensitive competitors versus the creation of privileged nutrients, analogous to strategies delineated for the enteric pathogen Salmonella Typhimurium, remains to be determined 2 . Furthermore, although SCFAs can directly inhibit bacterial growth and affect C. difficile toxin production, additional work is needed to investigate the potential roles of other relevant factors that could be affecting infection dynamics. For example, SCFAs can signal through host pathways (for example, improved barrier function via hypoxia-inducible factor 30 ), which may influence inflammation and the microbiome composition independently of C. difficile burdens and toxin production; other metabolites such as bile acids can influence CDI 6 and may interact with dietary effects.
Despite the individuality in the gut microbiota of patients with CDI, there is a consistent metabolic response that underlies CDI across individuals 25 . In light of observations that MACs profoundly alter the composition and function of the microbiota and host physiology 31 , our findings raise the possibility that SCFAs are a critical part of the metabolic landscapes tied to CDI status across individuals. To further address our hypothesis that SCFAs affect C. difficile growth and toxin production in the gut, we conducted SCFA-and tributyrin-feeding experiments in mice that were fed the MD1 diet. These experimental approaches are both intended to increase the levels of SCFAs (acetate, propionate and butyrate, or only butyrate, respectively) experimentally in the MD1 dietary condition, in the absence of MAC introduction and accompanying microbiota metabolic activity. Specifically, starting at 1 day pre-infection, mice were fed a cocktail of acetate, propionate and Supplementary Fig. 6 for the time points of euthanization corresponding to measurements. Data points represent per-sample concentration of each SCFA, and the bars represent the mean per-diet SCFA concentration. Significance was assessed by ordinary one-way ANOVA and Tukey's multiple comparison test (**P < 0.01, ****P < 0.0001; see also Supplementary Table 5 ). b, Doubling time was calculated for C. difficile grown in CDMM supplemented with 0, 10 and 30 mM sodium acetate (NaOAc), sodium propionate (NaOPr), sodium butyrate (NaOBu) or sodium chloride (NaCl, sodium-matched controls) as described in the Methods section. For each growth condition, n = 12 independent cultures were assessed. c, TcdB was quantified in supernatants from n = 12 independent cultures from each growth condition (corresponding to those analysed in panel b) as described in the Methods section. Points represent the mean values, error bars represent ± s.e.m. (panels b and c). Significance was assessed for each SCFA and sodiummatched controls at each concentration via the Mann-Whitney test (****two-tailed P < 0.0001; see also Supplementary Table 5 ).
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There was neither a significant difference in the levels of C. difficile recovered from the faeces of these mice nor a significant difference in the levels of TcdB detected in the faeces of these mice.
In addition, the levels of SCFAs in caecal contents at day 7 postinfection were not different between treatment groups. SCFAs are metabolites that have regulatory and metabolic roles in the host and the microbiota, and the pleiotropic roles that they have in mediating interspecies interactions are just beginning to be appreciated. Currently, several technical hurdles exist to experimentally manipulating SCFAs within the colon, which presents a tremendous opportunity to develop methods that enable the exploration of this important class of fermentation end products and their effects on gut ecology. For example, the negative results reported in Supplementary Fig. 14 highlight the need to develop precise methods to reproducibly alter SCFA concentrations in the distal gut. The cocktail of SCFAs that we used was previously shown to affect SCFA levels in the caecal contents and faeces of germ-free mice 32, 33 . Perhaps mice need to be provided with this cocktail for a longer period of time to see an effect (at least 21 days in the above studies), or the presence of a resident microbiome affects host absorption or microbial metabolism of SCFAs. We also gavaged mice with tributyrin in an attempt to elevate the levels of butyrate (which differentiates the C. difficile-permissive and C. difficilenon-permissive dietary conditions; see Fig. 3a ) in a more targeted manner in the distal gut 30, 34 in our infected animals. In our work, we reasoned that the levels of butyrate would remain elevated for the duration of the experiment if mice were gavaged daily with tributyrin, especially given that a previous study reported increased levels of butyrate in the caeca of mice at 24 hours post-tributyrin gavage 30 . Notably, a difference between our work and the previous studies that used tributyrin to alter the levels of butyrate in the gut was the timing of measurement of butyrate in the caeca relative to antibiotic treatment. In both studies, butyrate was measured soon after antibiotic treatment (within 35 hours post-antibiotic treatment 34 ). In our work, we measured SCFA levels 8 days after antibiotic treatment. Thus, it is possible that differences in the microbiota at the time of analysis (for example, antibiotics may deplete microorganisms that encode tributyrin-active lipases 35 in the small intestine, enabling delivery of higher concentrations to the caecum) are the basis of the observed differences. Other factors that differentiate the experimental setup, such as the use of a MD diet in our experiments, may also be contributing. Previously, it was shown that MACs influence lipolysis of tributyrin in vitro 36 , raising the possibility that a MAC-rich diet might allow for higher levels of butyrate to be delivered more distally in mice fed MAC-rich diets.
Current microbiota-centric therapies for CDI, such as faecal microbiota transplantation and probiotic administration, focus on the introduction of exogenous organisms. Our work in mice shows that dietary intervention supports microbial communities that exclude C. difficile without the requirement for microorganism introduction. Regardless of the inter-experiment and inter-animal variations in clearance kinetics ( Supplementary Fig. 8 ), the effect is highly reproducible. Clearance kinetics may be further affected by host genetics, initial microbiota composition or the overall dietary MAC concentration/composition.
Notably, two independent human trials have shown that cooked green bananas (which are rich in MACs, as demonstrated by elevated levels of SCFAs in the stool of treated patients) aid host recovery from another enteric pathogen, Shigella 37,38 . More recently, it was shown that a MD diet leads to microbiota-dependent mucus degradation and attachment-dependent lethal colitis by the murine pathogen Citrobacter rodentium 39 . Taken together, our work is part of a growing body of literature providing evidence that dietary manipulation of the metabolic networks of the intestinal tract is a powerful and underexplored way to influence gastrointestinal pathogens. Age-matched, female, humanized Swiss-Webster mice were fed the MD1 diet and underwent experimental CDI as in Fig. 1 or were mock infected with filter-sterilized PBS. After 7 days of infection, mice were switched either to the MAC + or inulin-containing diet. a, Mice were euthanized at time points specified in Supplementary Table 4 . Histopathology was carried out on proximal colon tissue from these mice, as described in the 'Histology and histopathological scoring' section of the Methods section (n = 4, n = 9 and n = 4 for mock-infected mice fed the MD1 diet, the MAC + diet and the inulin diet, respectively; and n = 13, n = 15 and n = 5 for infected mice fed the MD1 diet, the MAC + diet and the inulin diet, respectively). Points represent the sum histopathological score, and lines are drawn at the mean score for each group (see Supplementary Table 4 for individual parameters scored).
Significance between the relevant groups was assessed by unpaired t-test (*two-tailed P < 0.05, **two-tailed P < 0.01, NS, not significant). b, For infected mice where > 5 mg faecal material could be collected (n = 14, n = 13 and n = 13 for mice at 0, 2 and 4 days post-MD1 to MAC + diet shift; n = 8, n = 9 and n = 6 for mice at 0, 2 and 4 days post-MD1 to inulin diet shift; and n = 5, n = 9 and n = 9 at matched time points for mice that were maintained on the MD1 diet), the levels of TcdB in the faeces were measured and normalized to the burdens of C. difficile detected. Points represent the normalized TcdB abundance for individual faecal samples. Lines are drawn through geometric mean normalized toxin abundances. For mice switched to the MAC + diet, the normalized TcdB abundance increases 14.5-fold from day 0 to day 2 (P < 0.0001) and 6.5-fold from day 0 to day 4 (P = 0.0066).
For mice switched to the inulin diet, the normalized TcdB abundance increases 8.0-fold from day 0 to day 2 (P = 0.0016) and 6.5-fold from day 0 to day 4 (P = 0.0426). Significance between relevant pairs of treatment groups was assessed by the Mann-Whitney test (*two-tailed P < 0.05, **two-tailed P < 0.01, ****two-tailed P < 0.0001; see also Supplementary Table 5 ).
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Methods Media and bacterial growth conditions. Frozen stocks of the C. difficile strain 630 (ref. 40 ) were maintained under anaerobic conditions in septum-topped vials. C. difficile 630 was routinely cultured on CDMN agar composed of C. difficile agar base (Oxoid) supplemented with 7% defibrinated horse blood (Lampire Biological Laboratories), 32 mg l -1 moxalactam (Santa Cruz Biotechnology) and 12 mg l -1 norfloxacin (Sigma-Aldrich) in an anaerobic chamber at 37 °C (Coy). After 16-24 h of growth, a single colony was picked into 5 ml pre-reduced RCM (Oxoid) and grown for 16 h. This 16-h culture was used to inoculate mice. For in vitro experiments, C. difficile 630 was cultured on CDMN as above. Single colonies were picked into pre-reduced CDMM medium without glucose, as described previously 41 . After 16 h of growth, subcultures were prepared at a 1:200 dilution in pre-reduced CDMM supplemented with 0, 10 or 30 mM of sodium acetate (Fisher), sodium propionate (Sigma-Aldrich), sodium butyrate (Sigma-Aldrich) or sodium chloride (EMD Millipore) in sterile polystyrene 96-well tissue culture plates with low evaporation lids (Falcon). To further minimize the evaporation of culture media during growth, the 36 wells along the perimeter of the 96-well plates were filled with water rather than culture. Cultures were grown anaerobically as above in a BioTek Powerwave plate reader. At 15-min intervals, the plate was shaken on the 'slow' setting for 1 min and the optical density at 600 nm (OD 600 ) of the cultures was recorded using Gen5 software (version 1.11.5). After 24 h of growth, culture supernatants were collected after centrifugation (5 min at 2,500g) and stored at − 20 °C for quantification of TcdB (see 'Quantification of the C. difficile toxin TcdB' , below).
Murine model of CDI.
All animal studies were conducted in strict accordance with the Stanford University Institutional Animal Care and Use Committee (IACUC) guidelines. Murine model of CDI was performed on age-matched and sex-matched mice between 8 and 17 weeks of age, possessing one of three gut microbiota colonization states: (1) humanized Swiss-Webster mice: female germfree mice (Taconic; bred in house) were inoculated with a faecal sample obtained from a healthy anonymous donor, which was used in previous studies from our laboratory 42, 43 ; (2) male conventionally reared Swiss-Webster mice (Taconic; bred in house) or male C57BL/6 mice (B6EF, Taconic; experiments conducted on animals acquired directly from the vendor); and (3) conventionalized mice: male germ-free Swiss-Webster mice were inoculated with a faecal sample obtained from conventionally reared Swiss-Webster mice. The gut microbiomes of the humanized and conventionalized mice were allowed to engraft for at least 4 weeks 44 . The faecal sample used for humanizations was de-identified and obtained with informed consent of the donor.
To initiate CDI, mice were given a single dose of clindamycin by oral gavage (1 mg; 200 µ l of a 5 mg ml -1 solution) and were infected 24 h later with 200 µ l of overnight culture grown in RCM (approximately 1.5 × 10 7 c.f.u. per ml) or mock infected with 200 µ l filter-sterilized PBS. To reactivate CDI in mice that had cleared the infection below detection, mice were given a single dose of clindamycin as above.
Faeces were collected from mice directly into microcentrifuge tubes and placed on ice. To monitor C. difficile burdens in faeces, 1 µ l of each of faecal sample was resuspended in PBS to a final volume of 200 µ l, 10-fold serial dilutions of faecal slurries (through 10 -3 -fold) were prepared in sterile polystyrene 96-well tissue culture plates (Falcon). For each sample, duplicate 10 µ l aliquots of each dilution (technical replicates) were spread onto CDMN agar. After 16-24 h of anaerobic growth at 37 °C, colonies were enumerated and technical replicates were averaged to give c.f.u. values (limit of detection = 2 × 10 4 c.f.u. per ml faeces). C. difficile was undetectable in all mice prior to inoculation with C. difficile ( Fig. 1a and Supplementary Figs. 1,6-8 ) and in all mice that were mock infected with PBS ( Supplementary Fig. 8 ), supporting that the animals used in this work were not pre-colonized with C. difficile (for example, C. difficile LEM1, as seen previously 45 ). After serial dilution of faecal samples, the remaining amounts of faecal samples were immediately frozen at -80 °C until needed for 16S rRNA analysis and TcdB enzyme-linked immunosorbent assays (below). It was not possible to blind researchers to infection or dietary status of the animals.
C. difficile burdens were chosen as the benchmark for significance between persistent infection and MAC-mediated CDI suppression. The number of mice required per experimental group was chosen based on a power calculation for continuous variables for a power of 80% and a significance of 95% according to the equation n = 1 + 2 C (s/d) 2 , where n = the individuals required per experimental group, C = a constant based on significance and power (C = 7.85), s = the estimated population standard deviation and d = the difference to be detected 46 . Based on the burdens of C. difficle in persistently infected mice fed the MD1 diet ( Fig.  1a; 1-36 days post-infection, 60 independent measurements), the mean logtransformed C. difficile burden in faeces is 7.58 log c.f.u. per ml faeces with a s.d. of 0.59 log c.f.u. per ml faeces. Assuming a 95% confidence interval and 80% experimental power, 2.37 mice (3 mice rounded up) are needed to accurately determine at least a 2-log reduction in C. difficile burdens from the persistently infected state. Thus, our choice of 3-5 mice per group provides adequate power to discern when the burdens of C. difficile have decreased below 4.3 log c.f.u. per ml faeces.
Mouse diets. Mice were fed one of four diets in this study ad libitum: (1) a diet containing MAC + (5010, Purina LabDiet); (2) a custom MD diet 47 (MD1, 68% glucose (w/v), 18% protein (w/v) and 7% fat (w/v) (Bio-Serv)); (3) a commercially available MD diet (MD2, 34% sucrose (w/v), 17% protein (w/v), 21% fat (w/v); TD.88137, Harlan); or (4) a custom diet containing inulin as the sole MAC source 47 , which is based on the MD1 diet (58% glucose (w/v), 10% inulin (w/v) (Orafti HP, Beneo-Orafti group), 18% protein (w/v) and 7% fat (w/v) (Bio-Serv)). Where applicable (see Supplementary Fig. 7) , the drinking water of mice fed the MD1 diet was supplemented with 1% inulin (w/v) (Orafti HP, Beneo-Orafti group). Because mice consume approximately 5 g of food per day and 5 ml of water per day 48 , water with 1% inulin gives an approximate 10-fold reduction in inulin consumed relative to the 10% inulin diet. Where applicable (see Supplementary  Fig. 14) , mice fed the MD1 diet were gavaged daily with 200 µ l tributyrin (Sigma-Aldrich) or were given a cocktail of sodium acetate (67.5 mM; Fisher), sodium propionate (25 mM; Sigma-Aldrich) and sodium butyrate (40 mM; Sigma-Aldrich) in their drinking water 32 starting 1 day pre-infection. Groups of mice were randomly assigned to dietary conditions. Histology and histopathological scoring. Proximal colon sections harvested for histopathological analyses were fixed in 10% buffered neutral formalin and routinely processed for paraffin embedding, sectioned at 4 µ m, mounted on glass slides and stained with haematoxylin and eosin (Histo-tec Laboratory, Hayward, CA, USA). Analyses were performed by a board certified veterinary pathologist, using a semiquantitative scoring system 49 that evaluated the distribution and severity of cellular infiltrates (inflammation), gland hyperplasia, oedema and epithelial disruption using a severity score of 0-5 (0 = no significant lesion, 1 = minimal lesion, 2 = mild lesion, 3 = moderate lesion, 4 = marked lesion and 5 = severe lesion; see Supplementary Table 4 ).
Quantification of the C. difficile toxin TcdB. Levels of TcdB in culture supernatants and faeces were quantified relative to a standard curve of purified TcdB using the Separate Detection of C. difficile Toxins A and B Kit (TGC Biomics) according to the instructions that are readily available on the manufacturer's website. For culture supernatants that were harvested at 24 h post-inoculation (see 'Media and bacterial growth conditions' , above), toxin abundance was normalized by the final OD 600 of the culture and normalized TcdB abundance in culture supernatant = ((x ng toxin)/(y OD 600 )) and is reported in Fig. 3c . For each faecal sample, toxin abundance was normalized by the number of c.f.u., as determined by selective culture on CDMN agar (above), for each sample; normalized TcdB abundance in faeces = ((x ng toxin g -1 faeces)/(y c.f.u. C. difficile ml -1 faeces)) and is reported in Fig. 4b . The non-c.f.u.-normalized TcdB abundance (ng toxin g -1 faeces) in mouse faeces is reported in Supplementary Fig. 13 .
16S rRNA amplicon sequencing and OTU picking methods. Total DNA was extracted from frozen faecal material using the PowerSoil DNA Isolation Kit (MoBio) or the Powersoil-htp 96-well DNA Isolation Kit (MoBio). Barcoded primers were used to amplify the V3-V4 region of the 16S rRNA gene from extracted bacterial DNA using the primers 515f and 806rB via PCR 50 . Amplicon clean-up was performed using the UltraClean PCR Clean-Up Kit (MoBio) and quantification was performed using the high-sensitivity Quant-iT dsDNA Assay Kit (Thermo Fisher). Amplicons were pooled to an equimolar ratio. Amplicons from three mouse experiments were sequenced in three different paired-end Illumina MiSeq runs, with each experiment occurring on a separate run. The sample split/run corresponds to the field 'Experiment' in Supplementary Table 1 .
For commands executed for the 16S rRNA-based bioinformatics analysis, see Supplementary Code 1, an ipython notebook. Runs were demultiplexed independently owing to some non-unique barcodes and then concatenated prior to OTU picking using 'split_libraries_fastq.py' with default quality parameters in QIIME 1.9.1 (ref. 51 ). Open reference OTU picking was conducted with default parameters using the QIIME script 'pick_open_reference_otus.py' (with default clustering algorithm UCLUST 52 ) on the 24,582,127 reads that passed quality filtering. OTUs whose representative sequence failed to align to the Greengenes reference alignment with 85% identity using PyNAST were discarded 53, 54 .
We removed OTUs occurring in fewer than 10 samples and/or having < 26 counts in the entire data set. This filtering reduced the number of OTUs by 95.04% (211,884 to 10,504) but removed 5.2% of the feature mass (23,293,178 to 22,078,743) . This type of filtering removes a vast number of features that are probably artefacts, boosts power by reducing false discovery penalties and concentrates analysis on biologically meaningful features. We rarefied our data to correct for differences in sequencing depth. To ensure our results were not artefacts of rarefaction depth, we conducted analyses at multiple rarefaction levels and our conclusions were not changed. We use OTU tables rarefied to 7,000 in this study, facilitating inter-run comparisons. Supervised learning. Using the 'supervised_learning.py' script from QIIME 1.9.1, the random forests classification method (with 10-fold cross-validation error estimation) was trained using an OTU table as prepared above in '16S rRNA amplicon sequencing and OTU picking methods' . The presence or absence of C. difficile in a faecal sample (as determined by selective culture) or current diet Letters Nature Microbiology were used as the class label category, corresponding to the field 'Plus_minus_Cd' and 'Current_diet' of Supplementary Quantification of SCFAs. Immediately following euthanasia at 32 days postinfection, caecal contents were removed from mice described in Supplementary  Fig. 6 , weighed and flash frozen in liquid nitrogen. Caecal contents (70-150 mg) were suspended in a final volume of 600 µ l in ice-cold ultra-pure water and blended with a pellet pestle (Kimble Chase) on ice. The slurry was centrifuged at 2,350g for 30 s at 4 °C and 250 µ l of the supernatant was removed into a septum-topped glass vial and acidified with 20 µ l high-performance liquid chromatography grade 37% HCl (Sigma-Aldrich). Diethyl ether (500 µ l) was added to the acidified caecal supernatant to extract SCFAs. Samples were then vortexed at 4 °C for 20 min on 'high' and then centrifuged at 1,000g for 3 min. The organic phase was removed into a fresh septum-topped vial and placed on ice. Next, a second extraction was performed with diethyl ether as above. The first and second extractions were combined for each sample and 250 µ l of this combined solution was added to a 300-µ l glass insert in a fresh glass septum-topped vial and the SCFAs were derivitized using 25 µ l N-tert-butyldimethylsilyl-N-methyltrifluoroacetamide (Sigma-Aldrich) at 60 °C for 30 min.
Analyses were carried out using an Agilent 7890/5975 single quadrupole gas chromatograph-mass spectrometer. Using a 7683B autosampler, 1 µ l split injections (1:100) were made onto a DB-5MSUI capillary column (30-m length, 0.25-mm inner diameter and 0.25-µ m film thickness; Agilent) using helium as the carrier gas (1 ml min -1 , constant flow mode). Inlet temperature was 200 °C and the transfer line temperature was 300 °C. Gas chromatograph temperature was held at 60 °C for 2 min, ramped at 40 °C per min to 160 °C, then ramped at 80° per min to 320 °C and held for 2 min; the total run time was 8.5 min. The mass spectrometer used electron ionization (70 eV) and the scan range was m/z 50-400, with a 3.75-min solvent delay. Acetate, propionate and butyrate standards (20 mM, 2 mM, 0.2 mM, 0.02 mM and 0 mM) were acidified, extracted and derivatized as above, were included in each run and were used to generate standard curves to enable SCFA quantification.
Measurement of doubling time for in vitro growth experiments.
Raw OD 600 measurements of cultures grown in CDMM (see 'Media and bacterial growth conditions' , above) were exported from Gen5 to MATLAB and analysed using the growth_curve_analysis_v2_SCFA.m script and analyze_growth_curve_ SCFA.m function (Supplementary Codes 2 and 3, respectively). Growth rates were determined for each culture by calculating the derivative of natural logtransformed OD 600 measurements over time. Growth rate values at each time point were then smoothed using a moving average over 75-min intervals to minimize artefacts due to noise in OD measurement data. To mitigate any remaining issues with noise in growth rate values, all growth rate curves were also inspected manually. Specifically, in cases where the analyze_growth_curve_SCFA.m function selected an artefactual maximum growth rate, the largest local maximum that did not correspond to noise was manually assigned as the maximum growth rate. Doubling time was then computed by dividing the natural log of 2 by the maximum growth rate. The investigator that conducted the growth curve analysis was blinded to the experimental conditions where growth curve data were obtained.
Statistical methods. Alpha and beta diversity, correlations and random forests were computed using QIIME 1.9.1 ('alpha_diversity_through_plots.py' , 'beta_diversity_through_plots.py' , 'observation_metadata_correlations.py' and 'supervised_learning.py'). Kruskal-Wallis, Mann-Whitey, Student's t, analysis of variance (ANOVA) and D' Agostino-Pearson tests were performed using standard statistical analyses embedded in the Prism 7 software package (GraphPad Software). Spearman correlations were calculated in Python using Supplementary Code 1 under the heading 'Feature correlations by diet' . Specific statistical tests are noted in the figure legends or tables as applicable.
Reporting Summary. Further information on experimental design is available in the Nature Research Reporting Summary linked to this article.
Code availability. For the custom codes used in this study, see Supplementary Codes 1-3.
Data availability.
The data that support the findings of this study are available from the corresponding author upon request. The 16S rRNA sequence data are uploaded to Qiita (https://qiita.ucsd.edu/study/description/11349). Based on the burdens of C. difficile in persistently infected mice fed the MD1 diet ( Fig. 1B, 1-36 days post infection, 60 independent measurements), the mean logtransformed C. difficile burden in feces is 7.58 log cfu/mL feces with a standard deviation of 0.59 log cfu/mL feces. Assuming a 95% confidence interval and 80% experimental power, 2.37 mice (3 mice, rounded up) are needed to accurately determine at least a 2-log reduction in C. difficile burdens from the persistently infected state. Therefore, our choice of 3-5 mice per group provides adequate power to discern when the burdens of C. difficile have decreased below 4.3 log cfu/mL feces.
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